CorEvitas
This is a Prospective, observational research study for patients with NMOSD under the care of a licensed neurologist. Approximately 800 patients and 35 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
The objective of the registry is to create a cohort of patients with NMOSD. Data collected will be used to prospectively study the natural history of NMOSD, real-word effectiveness and safety of medications used to treat NMOSD, and drug utilization treatment patterns. Additionally, the data will be used to systematically evaluate the burden for patients with NMOSD and the impact of therapies on quality of life. This will be done through real time capture and adjudication of relapses, the standardized collection of patient-reported outcomes (PRO) and clinician-reported outcomes (ClinRO), the ac…
Inclusion Criteria: 1. Has a diagnosis of NMOSD at the time of enrollment according to the 2015 IPND consensus diagnostic criteria for NMOSD†. 2. Age 18 years or older at the time of enrollment. 3. Willing to provide Personal Information. Exclusion Criteria: 1. Has had a clinically confirmed NMOSD neuro-episode within the 12 weeks prior to enrollment. 2. Is participating or planning to participate in a double-blind randomized trial for an NMOSD drug. Note: Concurrent participation in another observational registry or open-label Phase 3b/4 trial is allowed. * All serology types (APQ4 +/-…
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.